🔗 Permalink

Inventor profile of:

Gerardo M. Castillo

City:

Bothell, Washington

Country:

United States

Published Applications:

Last publication date:

2026-01-15

Top Assignees for applications by Gerardo M. Castillo

The entities that hold a legal rights for patent applications filed by inventor Castillo Gerardo M.:

PharmaIN Corporation 14 Bothell, WA United States
PharmaIN Corporation 10 Seattle, WA United States
Pharmaln Corporation 4 Bothell, WA United States
ProteoTech Inc. 4 Kirkland, WA United States
Pharmaln Ltd. 1 Seattle, WA United States
PharmalN Corporation 1 Seattle, WA United States

Recent patent applications by Castillo Gerardo M.

Gerardo M. Castillo from Bothell, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-15

US20260015389A1

Chemistry; metallurgy

V1A Receptor Partial Agonist and Method of Use

#2 | 2024-10-03

US20240325544A1

Human necessities

CATIONIC LIPID FOR COVALENT MODIFICATION OF PEPTIDES

#3 | 2023-08-10

US20230248800A1

Human necessities

V1A Receptor Partial Agonist and Method of Use

#4 | 2020-08-13

US20200254100A1

Human necessities

ANIONIC-CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USING THE SAME

#5 | 2020-01-16

US20200017567A1

Chemistry; metallurgy

NPRA AGONISTS, COMPOSITIONS, AND USES THEREOF

#6 | 2018-11-01

US20180312642A1

Chemistry; metallurgy

Method of production of graft co-polymer excipient with a superior peptide and protein binding property

#7 | 2018-10-04

US20180280516A1

Human necessities

Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same

#8 | 2017-12-28

US20170368190A1

Human necessities

Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

#9 | 2016-12-15

US20160362523A1

Chemistry; metallurgy

Method of production of graft co-polymer excipient with a superior peptide and protein binding property

#10 | 2015-10-29

US20150307578A1

Chemistry; metallurgy

Composition for long-acting peptide analogs

#11 | 2015-10-08

US20150284476A1

Chemistry; metallurgy

Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

#12 | 2014-06-05

US20140154203A1

Human necessities

Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

#13 | 2014-02-20

US20140051628A1

Chemistry; metallurgy

Composition for long-acting peptide analogs

#14 | 2012-07-26

US20120190097A1

Human necessities

Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same

#15 | 2011-08-25

US20110207662A1

Chemistry; metallurgy

Composition for long-acting peptide analogs

#16 | 2011-03-17

US20110065657A1

Human necessities

Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases

#17 | 2010-09-16

US20100234279A1

Chemistry; metallurgy

Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

#18 | 2010-09-02

US20100221184A1

Human necessities

Compositions for delivery of therapeutics and other materials

#19 | 2010-08-05

US20100197778A1

Human necessities

PROANTHOCYANIDINS FOR THE TREATMENT OF AMYLOID AND ALPHA-SYNUCLEIN DISEASES

#20 | 2010-06-24

US20100158806A1

Human necessities

Compositions for delivery of therapeutics and other materials

#21 | 2010-04-22

US20100098636A1

Human necessities

Compositions for delivery of therapeutics and other materials

#22 | 2010-03-18

US20100069293A1

Human necessities

POLYMERIC CARRIER COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS, METHODS OF MAKING AND USING THE SAME

#23 | 2010-01-14

US20100010079A1

Human necessities

Proanthocyanidins for the Treatment of Amyloid and Alpha-Synuclein Diseases

#24 | 2009-08-06

US20090197965A1

Chemistry; metallurgy

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE

#25 | 2009-07-09

US20090176892A1

Chemistry; metallurgy

Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same

#26 | 2009-06-18

US20090156459A1

Chemistry; metallurgy

Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same

#27 | 2009-04-02

US20090088387A1

Chemistry; metallurgy

Composition for long-acting peptide analogs

#28 | 2009-03-12

US20090069432A1

Chemistry; metallurgy

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

#29 | 2009-02-26

US20090053169A1

Human necessities

Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same

#30 | 2008-08-28

US20080206162A1

Human necessities

Composition and methods for treating Alzheimer's disease and other amyloidoses

#31 | 2008-01-17

US20080015263A1

Human necessities

Compositions for delivery of therapeutics and other materials

#32 | 2007-10-02

US10821250

Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

#33 | 2007-09-27

US20070225362A1

Chemistry; metallurgy

Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis

#34 | 2007-06-21

US20070141145A1

Human necessities

HYDROPHOBIC CORE CARRIER COMPOSITIONS FOR DELIVERY OF THERAPEUTIC AGENTS, METHODS OF MAKING AND USING THE SAME

#35 | 2006-09-07

US20060199838A1

Chemistry; metallurgy

Substituted N-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies

#36 | 2005-11-03

US20050244334A1

Human necessities

Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders

InventorID:

659021 ⎘